Product Reports Resources Pricing Login Book a demo

Tilray

Biotech & Life Sciences · Nanaimo, Canada · Founded 2013 · IPO 2018

Medical cannabis research and production

Valuation $788M
Revenue $915M
EBITDA $19M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Talent graph

Tilray's talent

Book a demo to see the people
Employees mapped 997 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 31 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

1 investor on Tilray's cap table

Sourced from Dealroom's funding and investor records.

Series A 1 investor entered at this stage
Privateer Holdings

Global footprint

Where Tilray has talent and traffic

Workforce by country
14 countries with
team presence
🇨🇦 Canada57.2%
🇺🇸 United States23.5%
🇵🇹 Portugal15.1%
🇦🇺 Australia1%
🇩🇪 Germany1%
Top 5 of 14 shown
Web traffic by country
48K monthly visits
across markets
🇨🇦 Canada41.7%
🇺🇸 United States18.1%
🇵🇹 Portugal14%
🇬🇧 United Kingdom9%
🇦🇺 Australia3.8%
Top 5 markets shown

Patent intelligence

Tilray’s patent portfolio

Estimated portfolio value
$7M

22 active families in the valuation dataset.

Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.

Compare patent portfolios across companies →

Capital deployed

Tilray's 21 investments and acquisitions.

Every disclosed deal where Tilray appeared as a backer or acquirer, 2018–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

21 deals across Tilray's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Tilray deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Tilray's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        21 of 21 deals

        Market sentiment

        What the market is saying about Tilray

        An AI-synthesized read of the highest-engagement posts about Tilray on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Tilray on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles